XML 66 R51.htm IDEA: XBRL DOCUMENT v3.5.0.2
Financial Instruments and Fair Value Measures - Debt and Credit Facilities (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
May 31, 2016
May 31, 2015
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Mar. 31, 2015
Debt Instrument                
Proceeds from debt $ 7,700,000,000 $ 16,600,000,000            
Repayment of debt maturing more than three months 2,000,000,000              
Interest expense     $ 271,000,000 $ 207,000,000 $ 731,000,000 $ 511,000,000    
Short-Term Borrowings                
Short-term borrowings     0   0   $ 406,000,000  
Term loan facility | Bridge Term Loan Agreement                
Debt Instrument                
Drawn amount               $ 0
Interest expense           $ 86,000,000    
Senior notes                
Debt Instrument                
Principal amount of unsecured senior notes 7,800,000,000.0 16,700,000,000.0            
Debt issuance costs 52,000,000 93,000,000            
Debt discounts 29,000,000              
Senior notes | 2.30% Senior notes due 2021                
Debt Instrument                
Principal amount of unsecured senior notes $ 1,800,000,000.0              
Interest rate percentage 2.30%              
Senior notes | 2.85% Senior notes due 2023                
Debt Instrument                
Principal amount of unsecured senior notes $ 1,000,000,000.0              
Interest rate percentage 2.85%              
Senior notes | 3.20% Senior notes due 2026                
Debt Instrument                
Principal amount of unsecured senior notes $ 2,000,000,000.0              
Interest rate percentage 3.20%              
Senior notes | 4.30% Senior notes due 2036                
Debt Instrument                
Principal amount of unsecured senior notes $ 1,000,000,000.0              
Interest rate percentage 4.30%              
Senior notes | 4.45% Senior notes due 2046                
Debt Instrument                
Principal amount of unsecured senior notes $ 2,000,000,000.0              
Interest rate percentage 4.45%              
Financial institution                
Debt Instrument                
Proceeds used to finance accelerated share repurchase program $ 3,800,000,000 5,000,000,000            
Stemcentrx                
Debt Instrument                
Proceeds used to finance acquisition $ 1,900,000,000              
Pharmacyclics Inc                
Debt Instrument                
Proceeds used to finance acquisition   $ 11,500,000,000            
Commercial paper                
Short-Term Borrowings                
Short-term borrowings     $ 0   $ 0   $ 400,000,000  
Weighted-average interest rate (as a percent)     0.60% 0.20% 0.60% 0.20%